by Oleg Vishnevski | Jan 12, 2021 | Products
Hepcidin 25 HS & HIV Antiretroviral Therapy Study High levels of serum IL-6 and serum hepcidin and low CD4 cell count were risk factors of anemia of chronic disease in HIV patients on the combination of antiretroviral therapy. Abstract Purpose: This...
by Oleg Vishnevski | Sep 30, 2020 | News, Products
Testosterone Administration During Energy Deficit Suppresses Hepcidin and Increases Iron Availability for Erythropoiesis Context: Severe energy deprivation markedly inhibits erythropoiesis by restricting iron availability for hemoglobin synthesis. Objective:...
by Oleg Vishnevski | Sep 24, 2020 | News, Products
Role of Hepcidin to Identify the Type of Anemia in Chronic Kidney Disease in Children See full study: https://iopscience.iop.org/article/10.1088/1742-6596/1246/1/012023/meta Abstract Chronic kidney disease (CKD) may present with anemia of chronic disease (ACD),...
by Oleg Vishnevski | May 15, 2020 | News
Hepcidin Proficiency Test On April 30th, 2020, we received the final report of the first ever Hepcidin Proficiency Test. This study has being organized by Radboud University Medical Center (in Nijmegen, The Netherlands) in collaboration with SKML (the Dutch Foundation...
by Oleg Vishnevski | May 1, 2020 | Products
Can hepcidin be a useful marker in the diagnosis and monitoring of De Quervain thyroiditis? Endocrine Abstracts (2019) 63 GP182 | DOI: 10.1530/endoabs.63.GP182Dorota Filipowicz, Aleksandra Hernik, Ewelina Szczepanek-Parulska & Marek Ruchała Author affiliations...
